Arboretum Ventures reposted this
We’re delighted to share that ViaLase has been granted CE mark certification for the ViaLase Laser - the first femtosecond laser treatment for glaucoma! This achievement marks a significant clinical and regulatory milestone, paving the way for our commercial launch in Europe. A huge thank you to all our Advisory Board members for their invaluable guidance and expertise throughout this journey. Your support has been instrumental in achieving this milestone and bringing our pioneering technology to the European market. Read the full press release here: https://lnkd.in/etXC6V5c